Synchronoss price target lowered to $10 from $13 at Roth Capital

Roth Capital analyst Richard Baldry lowered the firm’s price target on Synchronoss (SNCR) to $10 from $13 and keeps a Buy rating on the shares. The company’s streamlined operations and elevated EBITDA levels of 2024 have been largely defended in 2025, with Q3 EBITDA of $12.0M only marginally below the $12.7M average of the prior six quarters, the analyst tells investors in a research note.